Endovia Health Sciences, Inc. has announced a special meeting of stockholders to take place on December 7, 2026. This meeting will address several significant proposals that could impact the company's capital structure and shareholder value.

The special meeting is set to be held virtually, allowing stockholders to participate from anywhere. Key proposals include the approval of the issuance of shares in excess of the current limits, an amendment to increase the number of authorized shares, and a potential reverse stock split.

Background

Endovia Health Sciences, Inc. operates within the beverages sector, classified under the SIC code 2080. The company is listed on the New York Stock Exchange under the ticker symbol EDVA. Recent filings include a definitive proxy statement filed on November 2, 2026, and an S-1 registration statement filed just days earlier on October 27, 2026. The company has undergone several name changes, previously known as Splash Beverage Group, Inc. and Canfield Medical Supply, Inc.

What the Filing Says

The definitive proxy statement filed with the SEC outlines several proposals for the upcoming meeting. Among them, stockholders will be asked to approve:

  • The issuance of 12,683,908 shares of common stock beyond the existing 19.99% limit, related to Series D convertible preferred stock and a convertible promissory note.
  • The initial issuance of up to 20,000,000 shares of common stock under an equity line of credit agreement.
  • An amendment to increase the number of authorized shares to 800,000,000.
  • A reverse stock split at a ratio determined by the board, ranging from one-for-two to one-for-49.
  • An adjournment of the meeting if necessary to gather sufficient votes.

These proposals are designed to provide the company with greater flexibility in managing its capital and responding to market conditions.

Impact

The outcomes of the proposals could significantly affect Endovia Health Sciences and its stockholders. The approval of the share issuances may provide the company with necessary capital to fund operations and growth initiatives. Additionally, the potential reverse stock split could impact share price and investor perception, as it is often seen as a method to enhance stock value.

What's Next

The special meeting is scheduled for December 7, 2026, at 10:00 AM Eastern Time. Stockholders are encouraged to vote their shares prior to the meeting to ensure a quorum. The company has set October 30, 2026, as the record date for determining stockholders eligible to vote.

For further details, stockholders can access the proxy materials through the company's designated website.